✦ LIBER ✦

Therapies for chronic hepatitis B: emerging roles for nucleoside analogues

✍ Scribed by Strasser, S. I. ;McCaughan, G. W.

Book ID: 109001213
Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 270 KB
Volume: 30
Category: Article
ISSN: 0004-8291
DOI: 10.1111/j.1445-5994.2000.tb00855.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Review article: nucleoside analogues for

Review article: nucleoside analogues for the treatment of chronic hepatitis B

✍ H. M. Younger; A. J. Bathgate; P. C. Hayes 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Combination therapy for chronic hepatiti

Combination therapy for chronic hepatitis B

✍ R J Fontana; A S Lok 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

ing Phase I and Phase II clinical trials. Other forms of experimental treatment that are being examined in in vitro and Currently, interferon alfa is the only approved treatment animal models include antisense oligonucleotides and supfor chronic hepatitis B virus (HBV) infection. A 3-to 6pressive HB

Dual therapy for chronic hepatitis B vir

Dual therapy for chronic hepatitis B virus

✍ Hussien Elsiesy; Douglas Dieterich 📂 Article 📅 2008 🏛 Current Science Inc. 🌐 English ⚖ 261 KB

Systematic review: combination therapies

Systematic review: combination therapies for treatment-naïve chronic hepatitis B

✍ M. KUMAR; S. K. SARIN 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

Interferon and nucleoside analog combina

Interferon and nucleoside analog combination therapy for hepatitis B

✍ Masahito Minami; Takayuki Katayama; Rei Sendo; Takeshi Okanoue; Toshikazu Yoshik 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 158 KB

Combination Therapy for Chronic Hepatiti

Combination Therapy for Chronic Hepatitis B: Current Indications

✍ Navin Paul; Steven-Huy Han 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 150 KB